Previous Article | Next Article 
Journal of Virology, August 2000, p. 7518-7528, Vol. 74, No. 16
0022-538X/00/$04.00+0
Effects of Deletion or Stringent Repression of the
H3L Envelope Gene on Vaccinia Virus Replication
Flávio G.
da
Fonseca,
Elizabeth J.
Wolffe,
Andrea
Weisberg, and
Bernard
Moss*
Laboratory of Viral Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892-0445
Received 22 March 2000/Accepted 17 May 2000
 |
ABSTRACT |
The C-terminal membrane anchor protein encoded by the H3L open
reading frame of vaccinia virus is located on the surfaces of
intracellular mature virions. To investigate the role of the H3L
protein, we constructed deletion (vH3
) and inducible (vH3i) null
mutants. The H3L protein was not detected in lysates of cells infected
with vH3
or vH3i in the absence of inducer. Under these conditions,
plaques were small and round instead of large and comet shaped,
indicative of decreased virus replication or cell-to-cell spread. The
mutant phenotype was correlated with reduced yields of infectious
intra- and extracellular virus in one-step growth experiments. The
defect in vH3i replication could not be attributed to a role of the H3L
protein in virus binding, internalization, or any event prior to late
gene expression. Electron microscopic examination of cells infected
with vH3
or vH3i in the absence of inducer revealed that virion
assembly was impaired, resulting in a high ratio of immature to mature
virus forms with an accumulation of crescent membranes adjacent to
granular material and DNA crystalloids. The absence of the H3L protein
did not impair the membrane localization of virion surface proteins
encoded by the A27L, D8L, and L1R genes. The wrapping of virions and
actin tail formation were not specifically blocked, but there was an
apparent defect in low-pH-mediated syncytium formation that could be
attributed to decreased virus particle production. The phenotypes of
the H3L deletion and repression mutants were identical to each other
but differed from those produced by null mutations of genes encoding
other vaccinia virus membrane components.
 |
INTRODUCTION |
Poxviruses are the largest and most
complex of all animal viruses. The first visible step in the assembly
of vaccinia virus, the prototype poxvirus, is the formation of crescent
membranes within viral factory areas of the cytoplasm (8).
The crescents enclose electron-dense material to become spherical
immature virions (IV) that progress into infectious intracellular
mature virions (IMV). Some IMV are then wrapped by a double layer of
membranes, derived from the trans-Golgi or endosomal cisternae, and
migrate to the periphery of the cell where the outermost viral and
plasma membranes may fuse (15, 17, 21, 35, 38). Virus spread is mediated largely by extracellular particles, which have one more
membrane than the IMV, and are called cell-associated extracellular enveloped virions (CEV) if they remain adherent and extracellular enveloped virions (EEV) if they are detached from the cell surface (2, 4, 5, 24).
Vaccinia virus mutants provide powerful tools for analyzing the
sequential steps in membrane formation and morphogenesis. For example,
studies with mutants indicated that (i) the F10L protein kinase is
required for formation of the first viral membranes (39,
43); (ii) small vesicles that may be precursors of the viral
membranes accumulate in the absence of A17L and A14L expression (28, 29, 40, 47); (iii) D13L expression is needed for coating the viral membranes to form crescents (50); (iv) IV accumulate when expression of L1R is blocked (25); (v) IMV
remain largely unwrapped by cisternae when A27R (27), F13L
(3), and B5R (12, 45) are not expressed; and (vi)
actin tail formation is dependent on synthesis of proteins encoded by
A33R, A34R, and A36R genes (30, 33, 46, 49).
We recently initiated investigations of the role of the H3L protein, an
immunodominant component of IMV membranes (18, 37, 51), and
presented evidence that it is anchored to the surfaces of IMV by a
C-terminal hydrophobic tail that can mediate posttranslational membrane
insertion (7). As a continuation of that study we constructed two vaccinia virus mutants, one with the H3L open reading
frame (ORF) deleted and the other with the H3L ORF stringently repressed, and found that immature viral forms accumulated, with a
corresponding reduction in infectious virions, under conditions in
which H3L was not expressed.
 |
MATERIALS AND METHODS |
Cells and viruses.
CV-1, RK13, and BS-C-1 cells
were grown in Earle's modified Eagle's medium (Quality Biological
Inc.) supplemented with 10% fetal calf serum. The vaccinia virus WR
strain and the recombinant vaccinia virus vT7LacOI (1) were
propagated in HeLa cells as described previously (10), and
stocks were maintained at
70°C.
Plasmids.
A copy of the H3L ORF containing NcoI
and BamHI sites at the respective 5' and 3' ends was
generated by PCR. The ATG of the NcoI site was used for
translation initiation without altering the coding sequence. PCR was
performed using vaccinia virus strain DNA as the template and primers
GGGCCATGGCGGCGGCGAAAACTCCTGTTATTGTTGTGCC and
GGGGGATCCTTATTAGATAAATGCGGTAACGAATGTTCCTGTAAGGAACC.
Restriction sites are underlined, and initiation and termination
codons are in italics. The PCR product was cut with NcoI and
BamHI and inserted into the pVOTE.1 plasmid (44)
to form pFFH3L. A 527-bp DNA segment corresponding to the downstream
flanking region of the H3L gene, comprising a portion of the H4L ORF,
was generated through PCR using vaccinia virus DNA as the template and
primers GGGGTCGACCGCCGCCGCCATTTAGTTATTGAAATTAATC and GGGAAGCTTCCTACTCCATCGGTCGAACCAACTG,
which contain SalI and HindIII
restriction sites at their 5' ends, respectively. The DNA fragment was
digested and inserted into SalI and HindIII
sites of the pZippy-NEO/GUS plasmid (provided by T. Shors), which
contains a copy of the neomycin resistance gene (neo) plus a
copy of the Escherichia coli
-glucuronidase gene flanked
by the multiple cloning sites, to form pFFH4LNG. Another DNA segment of
538 bp, containing the H3L upstream region and comprising a portion of the H2R ORF, was also generated by PCR. Vaccinia virus DNA was used as
the template, and the oligonucleotides
GGGAGATCTGGCTATAGTAGGCGTACAAGCAGCC and
GGGGCGGCCGCCACTATTCCATATTACTAAATCGGAACACCAATGCGG
with BglII and NotI sites at their 5' ends,
respectively, were used as primers. The DNA product was digested with
BglII and NotI and inserted into the pFFH4LNG
plasmid, which had been digested with same enzymes to form pFFH2RH4LNG.
Ready-to-Go PCR beads (Pharmacia Biotech) and the Expand High Fidelity
PCR system (Boehringer Mannheim) were used for PCR. Restriction enzymes
were from Gibco-BRL. The cloned segments of all plasmids were checked
by nucleotide sequencing.
Recombinant viruses.
Procedures for the construction and
propagation of recombinant viruses were similar to those previously
described (11, 47). vH3i was constructed as follows. CV-1
cells were infected with vT7LacOI at 0.5 PFU per cell and then
transfected with pFFH3L in Lipofectamine reagent and the Opti-Mem I
reduced medium system (Gibco-BRL Life Technologies) for 5 h. After
an additional 48 h of incubation, the cells were harvested and
diluted lysates were used to infect BS-C-1 monolayers in the presence
of mycophenolic acid. The monolayer was covered with agar, and
mycophenolic acid-resistant plaques were visualized with neutral red
and picked with a pipette. New BS-C-1 monolayers were infected with
individual plaques, and the cycle was repeated for three successive
rounds to generate vT7LacOI-H3L. CV-1 cells were then infected with
vT7LacOI-H3L and transfected with pFFH2RH4LNG as described above. The
lysates were used to infect BS-C-1 monolayers in the presence of 2 mg of Geneticin/ml and 50 to 100 µM isopropylthiogalactopyranoside (IPTG). Plaques that stained blue with 0.2 mg of
5-bromo-4-chloro-3-indolyl-
-D-glucuronic acid (X-Gluc;
Clontech, Palo Alto, Calif.)/ml were picked, and stocks of vH3i were
amplified in BS-C-1 cells in the absence of IPTG and maintained as
aliquots at
70°C.
vH3
was constructed by infecting CV-1 cells with wild-type vaccinia
virus and transfecting them with pFFH2RH4LNG. Plaques were formed on
BS-C-1 monolayers in the presence of Geneticin and picked after
staining with X-Gluc.
Western blot analysis.
BS-C-1 monolayers in six-well plates
were infected with vaccinia virus (10 PFU per cell) with or without
IPTG. After 24 h, the cells were harvested, collected by
centrifugation, and suspended in Laemmli reducing buffer (Sigma).
Proteins were separated on 4 to 20% polyacrylamide gradient sodium
dodecyl sulfate (SDS) gels (Owl Separation Systems) in a
Tris-glycine-SDS buffer system and transferred by electrophoresis to
membranes (Immobilon-P; Millipore). The membranes were blocked for
1 h in TTBS (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.05% Tween
20) containing 2.5% (wt/vol) dried nonfat milk. As the primary
antibody we used a 1:500 dilution of the H3L peptide rabbit antiserum
(7) or a rabbit antiserum generated against purified,
infectious vaccinia virus (provided by L. Potash). The membrane was
washed and incubated with an anti-rabbit horseradish conjugate
(Amersham Life Science). Immune complexes were detected with the
Super-Signal chemiluminescent detection kit (Pierce) and visualized
with X-Omat film (Kodak). Alternatively, anti-rabbit immunoglobulin G
alkaline phosphatase conjugate (Promega) was used as the secondary antibody.
Virus attachment to cells.
Confluent BS-C-1 cells in
six-well plates were cooled on ice for 30 min. Virus from cell lysates
was used to infect cells at a multiplicity of 1 PFU per cell. At
various times, the cells were washed twice with cold phosphate-buffered
saline (PBS), harvested, and collected by centrifugation. The cells
were then suspended in modified Eagle's medium containing 2.5% fetal
calf serum, serially diluted, and applied to duplicate fresh BS-C-1
monolayers for an infectious center assay.
One-step virus yield experiments.
Confluent BS-C-1 or
RK13 cells in six-well plates were infected with either
crude or sucrose gradient-purified vaccinia virus (10 PFU per cell).
After 1 h of adsorption, the medium was removed, the cells were
washed twice in PBS, and fresh medium was added. At various times, the
medium was removed and clarified by centrifugation and the cells were
washed and harvested. Cells were lysed by three cycles of freezing and
thawing, and lysates and clarified medium were sonicated separately.
Virus titers were determined by plaque assay on BS-C-1 cells.
Syncytium formation.
Confluent BS-C-1 or RK13
monolayers were infected with vaccinia virus (10 PFU per cell). After
adsorption, the inoculum was removed and replaced by fresh medium. The
infected cells were then incubated for 12 h at 37°C. Cells were
washed and treated for 2 min at 37°C with PBS containing 10 mM
2-(N-morpholino)ethanesulfonic acid (MES) and 10 mM HEPES,
pH 5.0 or 7.4. The fusion buffers were replaced by fresh medium, and
the cells were incubated for 1 to 3 h at 37°C and then
photographed with a phase-contrast microscope.
Electron microscopy.
RK13 cells were cultured in
60-mm-diameter dishes and infected with vaccinia virus (10 PFU per
cell). After 23 h, the cells were fixed in 2% glutaraldehyde in
0.1 M phosphate buffer (pH 7.4). Samples were then prepared by
osmication, dehydration, and embedding in Epon resin. Thin sections
were obtained, placed on grids, and stained with uranyl acetate and
Reynold's lead citrate (47). Images were acquired using a
Philips CM100 electron microscope. Immunogold labeling was performed as
described in the accompanying paper (7).
 |
RESULTS |
Construction of H3L mutant viruses.
A genetic approach was
taken to investigate the role of the H3L protein in vaccinia virus
replication. Two different types of mutants were constructed for this
purpose: a deletion mutant and an inducible mutant. The deletion
mutant, vH3
(Fig. 1A), was isolated by
infecting cells with vaccinia virus strain WR and then transfecting
them with a plasmid that contained neo and gus
expression cassettes replacing most of the H3L ORF but keeping the
adjacent H2R and H4L genes intact. Recombinant virus was selected in
the presence of Geneticin, and plaques that stained blue with X-Gluc
were picked repeatedly to obtain a pure clone. As will be shown later,
the plaques were smaller than those of parental WR virus. The genotype
of the mutant and the absence of contaminating WR were verified by PCR
analysis (data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Representation of wild-type and mutant genomes. (A)
Genomes of wild-type and recombinant viruses. Shown are genome segments
containing the following ORFs: J2R (encoding thymidine kinase) H2R,
H3L, H4L, and A56R (encoding hemagglutinin). In vH3 , the H3L ORF is
replaced by the neo and gus genes, which are
regulated by vaccinia virus promoters and which provide antibiotic
selection and positive identification of plaques. In vH3i, (i) the H3L
ORF is replaced by the neo and gus genes
regulated by vaccinia virus promoters, (ii) the bacteriophage T7 RNA
polymerase ORF regulated by the E. coli lac operator
(lacO) and the vaccinia virus P11 late promoter
(PL) and the E. coli lac repressor
(lacI) regulated by the vaccinia virus P7.5 early/late
promoter (PEL) are inserted into the J2R ORF, and (iii) the
H3L ORF preceded by the encephalomyocarditis virus untranslated leader
sequence (EMC) providing cap-independent translation, a modified
lacO (SLO), and a bacteriophage T7 promoter
(PT7) as well as the E. coli gpt gene regulated
by a vaccinia virus promoter for antibiotic selection are inserted into
the A56R ORF. (B) Expression of the H3L ORF. BS-C-1 cells that were
uninfected (UN) or infected with WR, vH3 , or vH3i in the presence
(+I) or absence ( I) of IPTG were harvested after 24 h and the
lysates were analyzed by SDS-PAGE and Western blotting with antiserum
to a peptide encoded by the H3L ORF. The H3L protein was detected by
chemiluminescence. The positions and masses of marker proteins are
indicated at the left.
|
|
The second type of mutant, vH3i, has a deleted H3L gene as well as a
new inducible one (Fig.
1A). We used a high-stringency
system (
44,
47) in which the recombinant vaccinia virus contained
three main
components: (i) a continuously expressed
Escherichia coli
lac repressor gene (
lacI), (ii) a bacteriophage T7 RNA
polymerase
gene regulated by a T7 promoter and a modified
E. coli
lac operator
(
lacO), and (iii) an inducible gene
regulated by the T7 promoter
and a modified
lacO. In this
system, the repressor inhibited two
consecutive steps: transcription of
the T7 RNA polymerase gene
and transcription of the inducible gene
thereby providing the
basis for high stringency. Controlled expression
of the inducible
gene was achieved by addition of the desired
concentration of
IPTG. To produce vH3i, we infected cells with the
WR-derived virus
vT7lacOI (
1), already carrying the
repressor and bacteriophage
T7 RNA polymerase genes. The infected cells
were then transfected
with a plasmid transfer vector (
44)
containing the H3L ORF regulated
by the T7 promoter and modified
lacO, the
E. coli gpt gene to
provide
mycophenolic acid resistance, and flanking sequences derived
from the
nonessential A56R ORF. The recombinant virus was plaque
purified in the
presence of mycophenolic acid, and the presence
of the inserted gene
was verified by PCR analysis. This intermediate-stage
virus still
contained the original H3L ORF as well as the new
inducible one. The
plasmid containing the
neo and
gus gene cassettes
replacing most of the H3L gene, used above to delete H3L from
WR, was
then transfected into cells that had been infected with
the
intermediate virus to form vH3i, which has a single H3L ORF
(Fig.
1A).
This step was carried out in the presence of IPTG to
ensure expression
of the inducible copy of the H3L gene during
isolation. After repeated
plaque purification, deletion of the
original H3L gene was verified by
PCR. Stocks of vH3i to be used
for experiments were made in the absence
of IPTG so that the virions
would lack the H3L protein as well as
traces of
inducer.
The mutant virus stocks were checked for H3L gene expression using an
antibody to an H3L-derived peptide (
7). H3L protein
synthesis could not be detected by SDS-polyacrylamide gel
electrophoresis
(PAGE) and immunoblotting of lysates from BS-C-1 cells
infected
for 24 h with vH3

or vH3i in the absence of IPTG (Fig.
1B). However,
the H3L protein was made in cells infected with vH3i in
the presence
of 100 µM IPTG (Fig.
1B).
Plaque phenotypes of vH3
and vH3i.
The ability to isolate a
virus with a deleted H3L gene indicated that the H3L gene was not
essential for replication. Nevertheless, vH3
plaques could be
distinguished from those of WR by their smaller size on BS-C-1
monolayers (Fig. 2A). A size difference between vH3i plaques that formed in the absence and presence of IPTG
was also noted (Fig. 2A). Even in the presence of IPTG, however, vH3i
plaques were smaller than those of WR, reflecting the slower replication of the parental vT7lacOI virus. The most striking difference in plaque phenotype was found with RK13 cells,
which are known to release large amounts of extracellular vaccinia
virus resulting in elongated or comet-shaped plaques (23).
The WR strain of vaccinia virus formed comet-shaped plaques by 48 h (Fig. 2B), albeit ones smaller than those formed by some other
vaccinia virus strains. In contrast, vH3
produced only small round
plaques during the same period (Fig. 2B). Moreover, vH3i produced
comet-shaped plaques in the presence of IPTG and round ones in the
absence of the inducer (Fig. 2B). The difference was not absolute,
however, because vH3
and vH3i in the absence of IPTG produced small
comets at 72 to 96 h. By that time, however, RK13 cell
monolayers infected with wild-type virus or vH3i in the presence of
IPTG were totally degraded by the spreading infection (data not shown).

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 2.
Plaque phenotypes of mutant viruses. (A) BS-C-1 cell
monolayers were inoculated with WR, vH3 , or vH3i in the presence
(+I) or absence ( I) of IPTG and stained with crystal violet after
48 h. (B) Same as panel A except that RK13 cells were
used.
|
|
Comparison of virus yields under one-step growth conditions.
A
small-plaque phenotype could result from inhibition of virus production
or spread. To investigate this, BS-C-1 cells were infected with 10 PFU
of purified virus per cell and the intra- and extracellular virus
yields were determined as a function of time. In BS-C-1 cells,
replication of both WR and vH3
was detected between 6 and 12 h
after infection. However, there was 10-fold more intracellular WR than
vH3
at 12 h and about 7.5-fold more at 24 h (Fig.
3A). A similar difference was found by
comparing levels of vH3i replication in the presence and absence of
IPTG (Fig. 3B). Although typically only small amounts of vaccinia virus are released from BS-C-1 cells, there was about fivefold more released
from cells infected with WR than from cells infected with vH3
(Fig.
3C) and also about fivefold more released from cells infected with vH3i
in the presence of IPTG than in the absence of IPTG (Fig. 3D). Similar
results were obtained when unpurified virus was used for infection,
indicating that the results were not due to instability of mutant
viruses in sucrose.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
One-step growth curves. BS-C-1 cells (A to D) and
RK13 cells (E to H) were infected with purified WR, vH3 ,
or vH3i in the presence (+I) or absence ( I) of IPTG as indicated. At
2, 6, 12, 24, and 48 h, the medium (C, D, G, and H) and cells (A,
B, E, and F) were harvested separately and infectious virus titers were
determined by plaque assay.
|
|
The results obtained with RK
13 cells were comparable to
those obtained with BS-C-1 cells. Viruses expressing the H3L protein,
WR and vH3i in the presence of IPTG, produced 7- to 10-times-higher
intracellular titers than viruses not expressing H3L protein,
vH3

and vH3i in the absence of IPTG (Fig.
3E and F). A similar
difference
in virus yield was found at 24 and 48 h, indicating
that the
absence of H3L protein does not merely delay the formation
of
infectious virus. Although the yields of extracellular vaccinia
virus
were higher in RK
13 cells than in BS-C-1 cells, there was
still about a fivefold advantage for a virus expressing H3L (Fig.
3G
and H). We concluded that there was an overall diminution in
production
of infectious virus by H3L mutants rather than a specific
defect in
formation of extracellular
particles.
Binding of virus to cells.
The difference in yields of vH3i in
the presence and absence of IPTG could not be explained by an effect on
virus binding or entry because the same virus stock prepared in the
absence of IPTG was used under both conditions. However, the lower
yield of vH3
than of WR might be partially explained by such
defects. To investigate binding, BS-C-1 cells were incubated on ice
with 1 PFU of either unpurified WR or vH3
/cell. At intervals, the cells were washed, harvested, and dispersed. An infectious-center assay
was then carried out by diluting the cells and plating them on fresh
BS-C-1 monolayers. Under these conditions, the rate of binding of
vH3
was nearly the same as that of WR (Fig.
4). Similar results were obtained when
the cells that had bound virus were frozen, thawed, and sonicated
before plaquing (data not shown). It is important to emphasize that
this assay compared the binding of infectious vH3
and WR rather than
physical particles. As will be noted later, the yield of IMV is greatly
reduced when H3L is not expressed, and consequently purified vH3
may
have a higher percentage of immature forms as well as other
contaminants than WR.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of infectious WR and vH3 to cells. Replicate
wells of chilled BS-C-1 cells were inoculated with 1 PFU of unpurified
WR or vH3 per cell and maintained on ice. At 1, 10, 20, 30, 45, and
60 min, cells were washed with cold PBS, harvested, dispersed, and
plated on fresh BS-C-1 monolayers at 37°C. After 48 h, the cells
were stained with crystal violet and the plaques were enumerated.
|
|
Viral protein synthesis.
To investigate the role of the H3L
protein in postbinding steps, cells were infected with 10 PFU of WR,
vH3
, or vH3i in the presence or absence of IPTG and then harvested
at various times. The cell lysates were analyzed by SDS-PAGE and
Western blotting using an antiserum that was prepared against purified
virions and which reacts strongly with late structural proteins
including H3L. By 12 h, similar patterns were present in all cases
(Fig. 5). The major difference between
the blots of cells infected with viruses expressing and not expressing
the H3L ORF was that the latter showed decreased labeling intensity in
the region of the gel expected to contain the H3L protein. The slightly
lower overall intensity of viral protein bands in cells infected with
vH3
than in cells infected with WR could be due small differences in
the rate of entry of H3L+ and H3L
virus. This
was not a factor in comparing results for vH3i in the presence and
absence of IPTG as the same virus stock was used in both cases. We
concluded that the H3L protein was not crucial for steps in virus
replication leading up to late protein synthesis.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 5.
Synthesis of viral proteins. BS-C-1 cells were infected
with WR, vH3 , or vH3i in the presence (+I) or absence ( I) of IPTG.
At 2, 6, 12, 18, and 24 h after infection, cells were harvested
and total proteins were subjected to SDS-PAGE. The resolved proteins
were transferred to membranes, probed with antiserum made in rabbits
infected with purified vaccinia virus, and detected by
chemiluminescence. The positions and masses of marker proteins are
shown on the left.
|
|
Electron microscopy of infected cells.
To further investigate
the stage at which virus replication was diminished as a consequence of
H3L deletion or repression, we used electron microscopy to examine thin
sections of RK13 cells infected with wild-type virus,
vH3
, or vH3i in the presence or absence of IPTG. After 23 h,
cells infected with WR contained large clusters of mature virions and
extracellular particles as well as some immature forms (Fig.
6A). In contrast, typical fields of cells
infected with vH3
contained predominantly crescents adjacent to
large masses of granular material and immature forms of virus (Fig. 6B
and C). DNA crystalloids, a hallmark of decreased morphogenesis
(14), were also found when the H3L protein was not made
(Fig. 6C). Although immature forms were predominant in cells infected
with vH3
, mature forms were occasionally seen and some cells
contained clusters of IMV (Fig. 6D). The wrapping of IMV was not
specifically blocked because intracellular enveloped virions (IEV) can
be seen in Fig. 6D and at a higher magnification in a subsequent
figure. The picture was similar in cells infected with vH3i: in the
presence of IPTG, typical fields showed clusters of mature virions as
well as some immature forms (Fig. 6E), whereas the latter were
predominant in the absence of IPTG (Fig. 6F). To confirm our visual
impression, the viral forms in random fields were enumerated. In
WR-infected cells, the intracellular mature forms comprising IMV and
IEV constituted 67% of the total, the CEV and EEV made up 25%, and
the crescents and IV totaled only 9% (Table
1). Similar numbers were obtained for
cells infected with vH3i in the presence of inducer (Table 1). In cells
infected with vH3
or vH3i in the absence of IPTG, however, the
crescents and IV constituted 61 to 70% of the total with
correspondingly lower numbers of intra- and extracellular mature forms
(Table 1).

View larger version (156K):
[in this window]
[in a new window]
|
FIG. 6.
Electron microscopy of ultrathin sections of infected
cells. RK13 cells were infected with WR (A), vH3 (B to
D), or vH3i in the presence (E) or absence (F) of IPTG and incubated
for 23 h. Abbreviations: C, crescents; I, IV; M, mature virions;
D, DNA crystalloids. Magnification is indicated by bars.
|
|
Incorporation of other membrane proteins into IV and IMV in the
absence of H3L expression.
Because the H3L protein can insert
directly into membranes via its hydrophobic C terminus, we considered
that it might have a role in the association of other viral membrane
proteins. The A27L, L1R, and D8L proteins also have a surface location,
and the latter two resemble H3L with regard to their C-terminal
hydrophobic domains. The A27L protein is largely hydrophobic and does
not have a typical transmembrane structure. To test this hypothesis, we
infected cells with vH3
or WR and then incubated cryosections with
an antibody to one of the three proteins followed by protein A-gold.
Both the A27L (36) and the L1R (48) proteins were previously reported to label immature virus forms to a lesser extent
than mature ones, and we found a similar situation with regard to D8L
(Fig. 7 and
8). However, in cells infected with vH3
, the labeling of IV appeared to be increased, particularly for
D8L, although this was not quantified (Fig. 7). If the association of
the surface proteins with viral membranes occurred at the same rate in
cells infected with vH3
and WR, the greater labeling of vH3
IV
could simply reflect their greater age due to the maturation block.
Although there were fewer clusters of mature virions in cells infected
with vH3
than in cells infected with WR, they were similarly labeled
with antibodies to L1R, A27L, and D8L proteins (Fig. 8). As seen in
Fig. 8, many of the virions are enclosed within cisternal membranes
indicating that they are IEV.

View larger version (167K):
[in this window]
[in a new window]
|
FIG. 7.
Detection of D8L, L1R, and A27L proteins on membranes of
IV formed in cells infected with vH3 or WR. Infected cells were
cryosectioned and incubated with antibody ( ) to D8L, L1R, or A27L
followed by protein A-gold. Insets show high magnification of IV
selected for good visualization of gold grains overlying the
membrane.
|
|

View larger version (147K):
[in this window]
[in a new window]
|
FIG. 8.
Detection of D8L, L1R, and A27L proteins on virion
membranes of cells infected with vH3 or WR. Immunogold labeling was
as described in the legend to Fig. 7. Insets show mature virions
selected for good visualization of gold grains overlying the
membrane.
|
|
Low-pH-induced fusion.
Brief low-pH treatment of cells
infected with vaccinia virus leads to formation of syncytia (9,
13). There appear to be at least two requirements for fusion:
expression of the A27L protein (13, 42) and formation of
extracellular virus particles (3, 45). We anticipated some
decrease in fusion due to decreased amounts of mature virions. To
examine this directly, BS-C-1 cells were infected at a multiplicity of
10 with WR, vH3
, or vH3i in the presence or absence of IPTG. After a
12-h incubation, the cells were treated briefly with fusion buffer (pH
5.0) or control buffer (pH 7.4) and incubated for 2 h more. Fusion
did not occur when the pH 7.4 buffer was used (Fig.
9). Extensive syncytia were present when
cells were infected with WR or vH3i in the presence of IPTG and treated
with pH 5.0 buffer (Fig. 9). In contrast, syncytia were not observed
under the same conditions when cells were infected with vH3
or vH3i
in the absence of IPTG (Fig. 9). Similar results were also obtained
with infected RK13 cells (data not shown). The absence of
detectable syncytia in cells infected with H3L mutants suggests that
the amount of CEV is insufficient to mediate this process or that the
H3L protein has an additional role in fusion.

View larger version (152K):
[in this window]
[in a new window]
|
FIG. 9.
Low-pH-induced fusion of infected cells. BS-C-1 cells
were infected with WR, vH3 , or vH3i in the presence (+I) or absence
( I) of IPTG. At 12 h after infection, the cells were immersed
briefly in buffer at pH 5.0 or 7.4. The medium was replaced, and the
incubation continued for an additional 3 h. The cells were
photographed with a phase-contrast microscope.
|
|
 |
DISCUSSION |
For the present study, we constructed a recombinant vaccinia virus
with an inducible H3L gene and then deleted the original one giving a
virus (vH3i) that produced smaller plaques in the absence than in the
presence of IPTG. Although we used a high-stringency repression system
and could not detect synthesis of the H3L protein in the absence of
inducer, the possibility of slight but biologically significant leakage
of gene expression that allowed small-plaque formation could not be
ruled out. Therefore, we also constructed a simple H3L deletion mutant,
vH3
. The ability to isolate this mutant established that the H3L
gene was not absolutely required for infectivity, though again the
plaques were much smaller and the titers of mutant virus stocks were
10-fold lower than those of wild-type virus. The availability of both
types of mutants proved extremely helpful. With the deletion mutant, we
could be confident that there was absolutely no H3L gene expression but could not entirely rule out negative effects on neighboring genes due
to the insertion or expression of the selection marker in the H3L
locus. In addition, differences in the titers or levels of purity of
mutant and wild-type viruses could have significant consequences. This
was a special concern because of the very low yield of vH3
compared
to that of wild-type virus. The main advantage of the inducible mutant
was that the effects of H3L gene expression could be studied using a
single virus stock by adding IPTG to one set of infected cells and none
to another. For most experiments, both types of mutants were used and
consistent results were obtained.
The defect in plaque formation was not as severe as that occurring with
some other mutant viruses that are defective in production of
extracellular virus particles or actin tails (3, 12, 20, 30, 32,
45, 49). Moreover, single-step growth experiments indicated that
the reduction in extracellular virus formation could be a secondary
consequence of the decrease of up to 1 log unit in the formation of
infectious intracellular virus. Electron microscopy revealed that
mature intracellular and extracellular virus particles could form in
the absence of H3L gene expression. However, the numbers of mature
particles were greatly reduced, and crescent membranes bordering large
granular masses and IV predominated. The relatively small amount of
extracellular virus could explain our inability to detect
low-pH-mediated fusion of cells. Another possibility is that the H3L
protein facilitates this process, which is thought to mimic
acid-induced fusion occurring during entry of EEV through an endosomal
pathway (41). Actin tails form on IEV and are important for
efficient cell-to-cell virus spread (6, 30, 31, 49). Actin
tails were visualized by immunofluorescence microscopy in cells
infected with vH3
or vH3i in the absence of inducer, indicating that
there was no specific block at this step (F. G. da Fonseca,
unpublished data).
The formation of crescents and immature virus particles in the absence
of H3L gene expression was consistent with antibody binding
experiments, which indicated that the H3L protein is normally associated predominantly with particles at a later stage of maturation (7). Therefore, unlike the A17L and the A14L gene products (26, 29, 40, 47), the H3L protein is not needed for the initial steps in virus membrane formation but apparently facilitates later steps in morphogenesis. It is interesting to compare the effects
described here with those of null mutations of other IMV surface
proteins. Repression of L1R expression also results in the accumulation
of IV but there seems to be a more complete block in formation of IMV
(25); repression of A27L expression has no effect on IMV
formation but prevents IMV transport and wrapping with modified Golgi
membranes to form IEV and EEV (27, 34); deletion of D8L has
no effect on morphogenesis, but the IMV have a lower infectivity
(16, 22).
In the accompanying paper (7), we show that the H3L protein
can insert posttranslationally into membranes via a C-terminal hydrophobic domain leaving the major portion of the protein
cytoplasmic. We considered that this cytoplasmic domain might interact
with other membrane proteins, namely, D8L, A27L or L1R, and recruit them to viral membranes. However, these three proteins were found associated with membranes of IV and mature forms in the absence of H3L.
The major defect of H3L null mutants appeared to be impaired virus
maturation. This was unequivocally demonstrated by infecting cells
under one-step growth conditions with the same H3L protein-deficient preparation of vH3i in the presence and absence of IPTG. We could conclude that the phenotype was due entirely to differences in de novo
synthesis of the H3L protein and not to any role of virion-associated H3L protein in the binding of virus to cells, internalization, or other
events prior to DNA replication and late gene expression. A quite
different experimental situation existed when infections with vH3
and wild-type vaccinia viruses were compared because the H3L protein is
absent from the IMV membrane in the former and present in the latter.
However, the similarity of the phenotypes of vH3
and vH3i in the
absence of IPTG suggested that the major defect was the same in both
cases. In addition, there was little difference in the binding of
infectious vH3
and wild-type virus to cells. If vH3
is less
infectious than wild-type virus, however, we may have obscured a
partial defect in binding by the design of our experiment.
Unfortunately, comparing the binding of physical particles was
problematic because preparations of the mutant virus were less pure
than those of wild-type virus and likely contained larger number of
immature forms due to the severe maturation block and the consequent
low virus yield. Relevant to this discussion is a report that appeared
during the final stage of preparation of our manuscripts. Lin et al.
(19) found that deletion of the H3L ORF interfered with
virus maturation and reduced virus infectivity and virulence. In
addition, they reported that an antibody to the H3L protein was
neutralizing and that a soluble, truncated form of the protein bound to
heparan sulfate and interfered with the binding of H3L protein to
cells. Therefore, the H3L protein may have roles in both virus
maturation and entry.
 |
ACKNOWLEDGMENTS |
We thank Christine White, Joanna Shisler, Linda Wyatt, and
Tatiana Senkevich for protocols, suggestions, and discussion of the
data and Norman Cooper for cells and viruses. Erna Kroon was instrumental in establishing the interaction between the
Laboratório de Vírus, ICB, UFMG, Brazil, and the
Laboratory of Viral Diseases.
Flavio G. da Fonseca is a graduate student at the Curso de Pós
Graduação em Microbiologia, Universidade Federal de Minas Gerais, Brazil, and was supported by the Fundação
Coordenação de Aperfeiçoamento de Pessoal de
Nível Superior and by a stipend from the National Institute of
Allergy and Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 4 Center Dr.,
MSC 0445, National Institutes of Health, Bethesda, MD 20892-0455. Phone: (301) 496-9869. Fax: (301) 480-1147. E-mail:
bmoss{at}nih.gov.
Present address: Laboratório de Vírus, Departamento
de Microbiologia, Instituto de Ciências Biológicas da
Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
 |
REFERENCES |
| 1.
|
Alexander, W. A.,
B. Moss, and T. R. Fuerst.
1992.
Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.
J. Virol.
66:2934-2942[Abstract/Free Full Text].
|
| 2.
|
Appleyard, G.,
A. J. Hapel, and E. A. Boulter.
1971.
An antigenic difference between intracellular and extracellular rabbitpox virus.
J. Gen. Virol.
13:9-17[Abstract/Free Full Text].
|
| 3.
|
Blasco, R., and B. Moss.
1991.
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein.
J. Virol.
65:5910-5920[Abstract/Free Full Text].
|
| 4.
|
Blasco, R., and B. Moss.
1992.
Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
J. Virol.
66:4170-4179[Abstract/Free Full Text].
|
| 5.
|
Boulter, E. A., and G. Appleyard.
1973.
Differences between extracellular and intracellular forms of poxvirus and their implications.
Prog. Med. Virol.
16:86-108[Medline].
|
| 6.
|
Cudmore, S.,
P. Cossart,
G. Griffiths, and M. Way.
1995.
Actin-based motility of vaccinia virus.
Nature
378:636-638[CrossRef][Medline].
|
| 7.
| da Fonseca, F. G., A. Weisberg, E. J. Wolffe,
and B. Moss. 2000. Characterization of the vaccinia virus H3L
envelope protein: topology and post-translational membrane insertion
via the C-terminal hydrophobic tail. 74:7508-7517.
|
| 8.
|
Dales, S., and L. Siminovitch.
1961.
The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy.
J. Biophys. Biochem. Cytol.
10:475-503[Abstract/Free Full Text].
|
| 9.
|
Doms, R. W.,
R. Blumenthal, and B. Moss.
1990.
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
J. Virol.
64:4884-4892[Abstract/Free Full Text].
|
| 10.
|
Earl, P. L.,
N. Cooper,
S. Wyatt,
B. Moss, and M. W. Carroll.
1998.
Preparation of cell cultures and vaccinia virus stocks, p. 16.16.1-16.16.3.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, New York, N.Y.
|
| 11.
|
Earl, P. L.,
B. Moss,
L. S. Wyatt, and M. W. Carroll.
1998.
Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.19.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, New York, N.Y.
|
| 12.
|
Engelstad, M., and G. L. Smith.
1993.
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Virology
194:627-637[CrossRef][Medline].
|
| 13.
|
Gong, S. C.,
C. F. Lai, and M. Esteban.
1990.
Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.
Virology
178:81-91[CrossRef][Medline].
|
| 14.
|
Grimley, P. M.,
E. N. Rosenblum,
S. J. Mims, and B. Moss.
1970.
Interruption by rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
J. Virol.
6:519-533[Abstract/Free Full Text].
|
| 15.
|
Hiller, G., and K. Weber.
1985.
Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.
J. Virol.
55:651-659[Abstract/Free Full Text].
|
| 16.
|
Hsiao, J. C.,
C. S. Chung, and W. Chang.
1999.
Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells.
J. Virol.
73:8750-8761[Abstract/Free Full Text].
|
| 17.
|
Ichihashi, Y.,
S. Matsumoto, and S. Dales.
1971.
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.
Virology
46:507-532[CrossRef][Medline].
|
| 18.
|
Jensen, O. N.,
T. Houthaeve,
A. Shevchenko,
S. Cudmore,
T. Ashford,
M. Mann,
G. Griffiths, and J. K. Locker.
1996.
Identification of the major membrane and core proteins of vaccinia virus by two-dimensional electrophoresis.
J. Virol.
70:7485-7497[Abstract].
|
| 19.
|
Lin, C. L.,
C. S. Chung,
H. G. Heine, and W. Chang.
2000.
Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.
J. Virol.
74:3353-3365[Abstract/Free Full Text].
|
| 20.
|
McIntosh, A. A., and G. L. Smith.
1996.
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
J. Virol.
70:272-281[Abstract].
|
| 21.
|
Morgan, C.
1976.
Vaccinia virus reexamined: development and release.
Virology
73:43-58[CrossRef][Medline].
|
| 22.
|
Niles, E. G., and J. Seto.
1988.
Vaccinia virus gene D8 encodes a virion transmembrane protein.
J. Virol.
62:3772-3778[Abstract/Free Full Text].
|
| 23.
|
Payne, L. G.
1979.
Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.
J. Virol.
31:147-155[Abstract/Free Full Text].
|
| 24.
|
Payne, L. G.
1980.
Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus.
J. Gen. Virol.
50:89-100[Abstract/Free Full Text].
|
| 25.
|
Ravanello, M. P., and D. E. Hruby.
1994.
Conditional lethal expression of the vaccinia virus L1R myristylated protein reveals a role in virion assembly.
J. Virol.
68:6401-6410[Abstract/Free Full Text].
|
| 26.
|
Rodríguez, D.,
M. Esteban, and J. R. Rodríguez.
1995.
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis.
J. Virol.
69:4640-4648[Abstract].
|
| 27.
|
Rodriguez, J. F., and G. L. Smith.
1990.
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.
Nucleic Acids Res.
18:5347-5351[Abstract/Free Full Text].
|
| 28.
|
Rodriguez, J. R.,
C. Risco,
J. L. Carrascosa,
M. Esteban, and D. Rodriguez.
1997.
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein.
J. Virol.
71:1821-1833[Abstract].
|
| 29.
|
Rodriguez, J. R.,
C. Risco,
J. L. Carrascosa,
M. Esteban, and D. Rodriguez.
1998.
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes.
J. Virol.
72:1287-1296[Abstract/Free Full Text].
|
| 30.
|
Roper, R.,
E. J. Wolffe,
A. Weisberg, and B. Moss.
1998.
The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
J. Virol.
72:4192-4204[Abstract/Free Full Text].
|
| 31.
|
Rottger, S.,
F. Frischknecht,
I. Reckmann,
G. L. Smith, and M. Way.
1999.
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation.
J. Virol.
73:2863-2875[Abstract/Free Full Text].
|
| 32.
|
Sanderson, C. M.,
F. Frischknecht,
M. Way,
M. Hollinshead, and G. L. Smith.
1998.
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.
J. Gen. Virol.
79:1415-1425[Abstract].
|
| 33.
|
Sanderson, C. M.,
F. Frischknecht,
M. Way,
M. Hollinshead, and G. L. Smith.
1998.
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.
J. Gen. Virol.
79:1415-1425.
|
| 34.
|
Sanderson, C. M.,
M. Hollinshead, and G. L. Smith.
2000.
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles.
J. Gen. Virol.
81:47-58[Abstract/Free Full Text].
|
| 35.
|
Schmelz, M.,
B. Sodeik,
M. Ericsson,
E. J. Wolffe,
H. Shida,
G. Hiller, and G. Griffiths.
1994.
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.
J. Virol.
68:130-147[Abstract/Free Full Text].
|
| 36.
|
Sodeik, B.,
S. Cudmore,
M. Ericsson,
M. Esteban,
E. G. Niles, and G. Griffiths.
1995.
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.
J. Virol.
69:3560-3574[Abstract].
|
| 37.
|
Takahashi, T.,
M. Oie, and Y. Ichihashi.
1994.
N-terminal amino acid sequences of vaccinia virus structural proteins.
Virology
202:844-852[CrossRef][Medline].
|
| 38.
|
Tooze, J.,
M. Hollinshead,
B. Reis,
K. Radsak, and H. Kern.
1993.
Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes.
Eur. J. Cell Biol.
60:163-178[Medline].
|
| 39.
|
Traktman, P.,
A. Caligiuri,
S. A. Jesty, and U. Sankar.
1995.
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of morphogenesis.
J. Virol.
69:6581-6587[Abstract].
|
| 40.
|
Traktman, P.,
K. Liu,
J. DeMasi,
R. Rollins,
S. Jesty, and B. Unger.
2000.
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant.
J. Virol.
74:3682-3695[Abstract/Free Full Text].
|
| 41.
|
Vanderplasschen, A.,
M. Hollinshead, and G. L. Smith.
1998.
Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
J. Gen. Virol.
79:877-887[Abstract].
|
| 42.
|
Vazquez, M. I., and M. Esteban.
1999.
Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.
J. Virol.
73:9098-9109[Abstract/Free Full Text].
|
| 43.
|
Wang, S., and S. Shuman.
1995.
Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2.
J. Virol.
69:6376-6388[Abstract].
|
| 44.
|
Ward, G. A.,
C. K. Stover,
B. Moss, and T. R. Fuerst.
1995.
Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells.
Proc. Natl. Acad. Sci. USA
92:6773-6777[Abstract/Free Full Text].
|
| 45.
|
Wolffe, E. J.,
S. N. Isaacs, and B. Moss.
1993.
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
J. Virol.
67:4732-4741[Abstract/Free Full Text].
|
| 46.
|
Wolffe, E. J.,
E. Katz,
A. Weisberg, and B. Moss.
1997.
The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.
J. Virol.
71:3904-3915[Abstract].
|
| 47.
|
Wolffe, E. J.,
D. M. Moore,
P. J. Peters, and B. Moss.
1996.
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.
J. Virol.
70:2797-2808[Abstract].
|
| 48.
|
Wolffe, E. J.,
S. Vijaya, and B. Moss.
1995.
A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.
Virology
211:53-63[CrossRef][Medline].
|
| 49.
|
Wolffe, E. J.,
A. S. Weisberg, and B. Moss.
1998.
Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread.
Virology
244:20-26[CrossRef][Medline].
|
| 50.
|
Zhang, Y., and B. Moss.
1992.
Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin.
Virology
187:643-653[CrossRef][Medline].
|
| 51.
|
Zinoviev, V. V.,
N. A. Tchikaev,
O. Chertov, and E. G. Malygin.
1994.
Identification of the gene encoding vaccinia virus immunodominant protein p35.
Gene
147:209-214[CrossRef][Medline].
|
Journal of Virology, August 2000, p. 7518-7528, Vol. 74, No. 16
0022-538X/00/$04.00+0
This article has been cited by other articles:
-
Bisht, H., Weisberg, A. S., Szajner, P., Moss, B.
(2009). Assembly and Disassembly of the Capsid-Like External Scaffold of Immature Virions during Vaccinia Virus Morphogenesis. J. Virol.
83: 9140-9150
[Abstract]
[Full Text]
-
Chung, C.-S., Chen, C.-H., Ho, M.-Y., Huang, C.-Y., Liao, C.-L., Chang, W.
(2006). Vaccinia Virus Proteome: Identification of Proteins in Vaccinia Virus Intracellular Mature Virion Particles. J. Virol.
80: 2127-2140
[Abstract]
[Full Text]
-
Resch, W., Moss, B.
(2005). The Conserved Poxvirus L3 Virion Protein Is Required for Transcription of Vaccinia Virus Early Genes. J. Virol.
79: 14719-14729
[Abstract]
[Full Text]
-
Davies, D. H., McCausland, M. M., Valdez, C., Huynh, D., Hernandez, J. E., Mu, Y., Hirst, S., Villarreal, L., Felgner, P. L., Crotty, S.
(2005). Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice. J. Virol.
79: 11724-11733
[Abstract]
[Full Text]
-
Resch, W., Weisberg, A. S., Moss, B.
(2005). Vaccinia Virus Nonstructural Protein Encoded by the A11R Gene Is Required for Formation of the Virion Membrane. J. Virol.
79: 6598-6609
[Abstract]
[Full Text]
-
Chung, C.-S., Huang, C.-Y., Chang, W.
(2005). Vaccinia Virus Penetration Requires Cholesterol and Results in Specific Viral Envelope Proteins Associated with Lipid Rafts. J. Virol.
79: 1623-1634
[Abstract]
[Full Text]
-
da Fonseca, F. G., Weisberg, A. S., Caeiro, M. F., Moss, B.
(2004). Vaccinia Virus Mutants with Alanine Substitutions in the Conserved G5R Gene Fail To Initiate Morphogenesis at the Nonpermissive Temperature. J. Virol.
78: 10238-10248
[Abstract]
[Full Text]
-
Unger, B., Traktman, P.
(2004). Vaccinia Virus Morphogenesis: A13 Phosphoprotein Is Required for Assembly of Mature Virions. J. Virol.
78: 8885-8901
[Abstract]
[Full Text]
-
Szajner, P., Jaffe, H., Weisberg, A. S., Moss, B.
(2003). Vaccinia Virus G7L Protein Interacts with the A30L Protein and Is Required for Association of Viral Membranes with Dense Viroplasm To Form Immature Virions. J. Virol.
77: 3418-3429
[Abstract]
[Full Text]
-
da Fonseca, F. G., Wolffe, E. J., Weisberg, A., Moss, B.
(2000). Characterization of the Vaccinia Virus H3L Envelope Protein: Topology and Posttranslational Membrane Insertion via the C-Terminal Hydrophobic Tail. J. Virol.
74: 7508-7517
[Abstract]
[Full Text]